Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Go Global International ApS
APS
Active
CVR 44294516
Humlehaven 2
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 398K
EBITDA margin
100.0%
Equity ratio
45.8%
Financial strength
Net profit 2024
DKK 308K
1 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK 398K
—
EBITDA
DKK 398K
—
Net profit
DKK 308K
—
Total assets
DKK 761K
—
Equity
DKK 348K
—
Employees
1
—
Company information
Legal name
Go Global International ApS
CVR number
44294516
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11. september 2023
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive handel, pakke og distribuere medico og aromatiske duftfiltre, samt enhver virksomhed i hermed stående forbindelse
Contact
Address
Humlehaven 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Fredensborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
398
Staff expenses
-0
EBITDA
398
Depreciation & amort.
-0
EBIT
398
Net financials
-0
Profit before tax
397
Tax
89
Net profit
308
Balance sheet
DKK thousands
Item
2024
Total assets
761
Equity
348
Long-term debt
0
Short-term debt
412
Total debt
412
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2024
2024
Equity ratio
45.8%
This company
38.2%
Market median
+20% vs market
2024
2024
Return on equity
88.5%
This company
18.4%
Market median
+381% vs market
2024
2024
Net profit margin
77.6%
This company
8.1%
Market median
+858% vs market
2024
2024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
2024
2024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-09-11 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
CL
Carsten Leonhard Knudsen
Management
Management
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
StyX Holding ApS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Vave Pharma Holding ApS
Vave Pharma Production ApS
StyX Holding ApS
Go Global International ApS
(this company)
Board network connections
Board members of Go Global International ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Carsten Leonhard Knudsen
Management
0 companies